2565 ADVICE - แนบเอกสารประกอบงบการเงิน-En Statement of Comprehensive Income (Consolidated) (Unit : Million Baht) 2021 2022 Increase (Decrease) %YoYAmount % Amount % Sales and services 14,305.82
business which Hemodialysis services for kidney patients who receive replacement therapy with Hemodialysis by Hemodialysis machinery (Hemodialysis Center) and distribution of medical equipment as well as
from the year 2017 or increased by 5% (Separated Financial Statement: 2,812 tons and 569,224 tons, for the year 2018 and 2017 respectively). Total revenue from sales and services of the Company and
which had been reviewed by the independent auditor as follows: 1. Summary of the Company’s operating results 2. Analysis of the consolidated financial performance 3. Analysis of the consolidated financial
Selling expenses 24.61 25.69 (1.08) (4.22) Administrative expenses 51.85 56.12 (4.27) (7.61) Financial Cost 0.49 0.49 0 0 Cost of sales and services increased by 22.34 million Baht or 3.19%, mainly came
cost of sales 700.41 682.01 18.40 2.70 Selling expenses 25.69 22.04 3.65 16.56 Administrative expenses 56.12 57.48 (1.36) (2.37) Financial Cost 0.49 0.60 (0.11) (18.33) Cost of sales and services
3.27 million Baht which was one-time expense whereas there was no the expense in this year. Finance Cost Financial cost increased by 2 million Baht; 1 million Baht from the Company. In the previous
3.27 million Baht which was one-time expense whereas there was no the expense in this year. Finance Cost Financial cost increased by 2 million Baht; 1 million Baht from the Company. In the previous
MANAGEMENT DISCUSSION & ANALYSIS 2Q 2018 14 AUG 2018 U CITY PCL 2Q 2018 MD&A (for the quarter ended 30 June 2018) 1 U CITY PCL 15 MAY 2018 2Q 2018 KEY FINANCIAL HIGHLIGHTS Total revenue rose
Plc. would like to inform the financial results for the third quarter of 2018 which ended on 30 September 2018. The Company and its subsidiary reported a net profit of THB 1.39 million or earnings per